Clinical Trials List
Protocol NumberJ1I-MC-GZBK
Completed
2023-07-17 - 2024-05-23
Phase III
Recruiting1
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 黃偉銘 無
- 游偉光 無
- Shih-Hsien Sung 無
- Hao-min Cheng 無
- Wen-Chung Yu 無
- 蔡依霖 無
- 李慶威 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1000 participants
